Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Design Therapeutics (DSGN) Cash & Current Investments: 2020-2021

Historic Cash & Current Investments for Design Therapeutics (DSGN) over the last 1 years, with Sep 2021 value amounting to $393.7 million.

  • Design Therapeutics' Cash & Current Investments was N/A to $393.7 million in Q3 2021 from the same period last year, while for Sep 2021 it was $1.2 billion, marking a year-over-year change of. This contributed to the annual value of $36.1 million for FY2020, which is N/A change from last year.
  • Design Therapeutics' Cash & Current Investments amounted to $393.7 million in Q3 2021, which was down 2.26% from $402.8 million recorded in Q2 2021.
  • Design Therapeutics' Cash & Current Investments' 5-year high stood at $411.3 million during Q1 2021, with a 5-year trough of $36.1 million in Q4 2020.
  • Its 2-year average for Cash & Current Investments is $311.0 million, with a median of $398.3 million in 2021.